June 27, 2012 | The Gates Foundation plans to take equity stakes in up to a dozen biotech companies this year, signalling a shift towards a “venture capital” approach at the world’s biggest philanthropic organisation. Trevor Mundel, the foundation’s recently appointed head of global health, hopes to oversee a series of investments in companies each likely to be worth several million dollars. Financial Times